Actively Recruiting
Use of Patient Samples and Corresponding Clinical Data for Research and Development Studies and/or Population-based Analysis
Led by Sequenom, Inc. · Updated on 2024-10-16
2000
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
S
Sequenom, Inc.
Lead Sponsor
L
Laboratory Corporation of America
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research involves using patient samples and clinical data for research and development or population-based analysis. It focuses on patients who have provided commercial samples to LabCorp or its affiliates, including those of scientific interest who may be followed up after giving informed consent. The study covers conditions related to pregnancy, cancer, and infectious diseases. The study has two groups: one uses leftover commercial samples and data that have been de-identified to protect personal health information for research purposes; the other involves collecting samples and data prospectively from patients who have given consent and are considered scientifically important by the sponsor or their doctor. Samples and data may be collected for up to 12 months after enrollment. Participants provide consent for their samples and data to be used or followed up if they are of scientific interest. Researchers will analyze these samples and data for research and development activities. The study tracks the use of remnant samples and data both retrospectively and prospectively, ensuring privacy compliance. Participation may include ongoing sample and data collection for up to one year after joining the study.
CONDITIONS
Brief Title
Compliant Analysis of Patient Samples and Data
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All samples and data are de-identified and HIPAA compliant for Arm 1
- Subject is of scientific interest to the Sponsor or treating physician for Arm 2
- Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected for Arm 2
You will not qualify if you...
- Subject is from a US state or country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development for Arm 1
- Any medical or mental condition that would interfere with the subject's ability to willingly give written informed consent for Arm 2
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 12 months after enrollment
Participants provide clinical samples and data which are collected for research and development purposes.
Visits occur as needed for sample and data collection during this period
Trial Site Locations
Total: 1 location
1
Sequenom, Inc
San Diego, California, United States, 92121
Actively Recruiting
Research Team
G
Graham P Senior Director
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here